diclofenac has been researched along with rilpivirine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, CH; Cherukupalli, S; Cocklin, S; De Clercq, E; Dick, A; Ding, X; Gao, P; Huang, T; Kang, D; Lee, KH; Liu, X; Meuser, ME; Pannecouque, C; Sun, L; Xu, S; Zalloum, WA; Zhan, P | 1 |
Daelemans, D; De Clercq, E; Gao, P; Ginex, T; Huang, B; Jiang, X; Kang, D; Liu, X; Luque, FJ; Pannecouque, C; Zhan, P; Zhang, J | 1 |
Chen, FE; De Clercq, E; Huang, WJ; Jin, X; Pannecouque, C; Wang, S; Zhang, YX; Zhao, LM | 1 |
3 other study(ies) available for diclofenac and rilpivirine
Article | Year |
---|---|
Design, Synthesis, and Mechanism Study of Benzenesulfonamide-Containing Phenylalanine Derivatives as Novel HIV-1 Capsid Inhibitors with Improved Antiviral Activities.
Topics: Animals; Anti-HIV Agents; Capsid Proteins; Cell Line, Tumor; Drug Design; Female; HIV-1; HIV-2; Humans; Male; Mice; Microsomes, Liver; Molecular Structure; Phenylalanine; Rats, Sprague-Dawley; Structure-Activity Relationship; Sulfonamides; Virus Replication | 2020 |
Structure-Based Design and Discovery of Pyridyl-Bearing Fused Bicyclic HIV-1 Inhibitors: Synthesis, Biological Characterization, and Molecular Modeling Studies.
Topics: Anti-HIV Agents; Cell Line; Drug Design; Heterocyclic Compounds, 2-Ring; HIV Reverse Transcriptase; HIV-1; Humans; Microsomes, Liver; Molecular Dynamics Simulation; Molecular Structure; Mutation; Protein Binding; Pyridines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 2021 |
Structure-Based Discovery of Novel NH
Topics: Anti-HIV Agents; Biphenyl Compounds; Drug Design; Heterocyclic Compounds, 1-Ring; HIV Reverse Transcriptase; HIV-1; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 2022 |